TeleCheck-AF for COVID-19

Linz, Dominik; Pluymaekers, Nikki A H A; Hendriks, Jeroen

doi:10.1093/eurheartj/ehaa404

Cited by 67 publications

(51 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…An example of such approach is TeleCheck-AF project, integrated, so far, in 37 European centers. [93] , [94] Further, this approach will change the current standard of care by reducing the number of hospital visits (planned and unplanned) and thereby reduce healthcare costs while maintaining appropriate AF treatment. Additionally, it may represent a good strategy to prepare for future crisis, when attendance of outpatient clinics or travelling to the hospital is not possible or undesirable.…”

Section: Long-term Management Of Af Patients With Covid-19 Infectionmentioning

confidence: 99%

COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications

Gawałko

Kapłon‐Cieślicka

Hohl

et al. 2020

IJC Heart & Vasculature

Self Cite

131

142

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the most prevalent arrhythmia in clinical practice. Here, we review the available evidence for prevalence and incidence of AF in patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and discuss disease management approaches and potential treatment options for COVID-19 infected AF patients.

show abstract

Section: Long-term Management Of Af Patients With Covid-19 Infectionmentioning

confidence: 99%

COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications

Gawałko

Kapłon‐Cieślicka

Hohl

et al. 2020

IJC Heart & Vasculature

Self Cite

131

142

View full text Add to dashboard Cite

show abstract

“…In keeping with the idea of remote telehealth services, a European project (TeleCheck-AF project featured on the ESC website: bit.ly/34R2F65) was recently launched for on-demand heart rate and rhythm monitoring in order to maintain AF management while keeping patients out of hospital during COVID-19 [94] . To date, 23 European hospitals across nine countries have joined the project.…”

Section: Digital Medicinementioning

confidence: 99%

COVID-19 infection and cardiac arrhythmias

Manolis¹,

Manolis

et al. 2020

Trends in Cardiovascular Medicine

109

View full text Add to dashboard Cite

Highlights Serious cardiac arrhythmias may be the consequence of direct effects of COVID-19 infection, but also the outcome of the deleterious effects of systemic illness and the adverse proarrhythmic reactions to drugs employed in the treatment of this pandemic Drug combinations, especially of QT-prolonging agents, can lead to higher arrhythmogenicity, compared with single drug therapies Furthermore, critically ill COVID-19 patients often have comorbidities that can trigger life-threatening ventricular arrhythmias, while acute myocardial injury increases the prevalence of arrhythmias ECG and QTc monitoring and taking appropriate measures are of critical importance to prevent, detect and manage cardiac arrhythmias in COVID-19 patients Contactless monitoring and telemetry for inpatients, especially those admitted to the ICU, as well as for outpatients needing continued management, has recently been facilitated by implementing digital health monitoring tools

show abstract

Section: Discussionmentioning

confidence: 99%

“…The TeleCheck-AF project is an epidemic response involving 36 hospitals in 13 countries (as of May 2020, and still increasing) leveraging the FibriCheck smartphone application to maintain AF management for patients remotely, and the research team has developed a suite of tools, including operating procedures and patient materials, to facilitate the adoption of the process by other hospitals. 35,36 With the increasing number of virtual clinical encounters in the COVID-19 pandemic, integration of commercial digital devices may increase the value of the virtual visit by providing HCPs access to heart rhythm information outside of conventional clinical settings. Notably, this survey was administered before the full impact of the pandemic was apparent, and practitioner perspectives regarding digital health technologies may have further shifted.…”

Section: Integration Of Digital Devices Into Af Carementioning

confidence: 99%

Survey of current perspectives on consumer-available digital health devices for detecting atrial fibrillation

Ding

Svennberg

Wurster

et al. 2020

Cardiovascular Digital Health Journal

View full text Add to dashboard Cite

BACKGROUND Many digital health technologies capable of atrial fibrillation (AF) detection are directly available to patients. However, adaptation into clinical practice by heart rhythm healthcare practitioners (HCPs) is unclear. OBJECTIVE To examine HCP perspectives on use of commercial technologies for AF detection and management. METHODS We created an electronic survey for HCPs assessing practice demographics and perspectives on digital devices for AF detection and management. The survey was distributed electronically to all members of 3 heart rhythm professional societies. RESULTS We received 1601 responses out of 73,563 e-mails sent, with 43.6% from cardiac electrophysiologists, 12.8% from fellows, and 11.6% from advanced practice practitioners. Most respondents (62.3%) reported having recommended patient use of a digital device for AF detection. Those who did not had concerns about their accuracy (29.6%), clinical utility of results (22.8%), and integration into electronic health records (19.8%). Results from a 30-second single-lead electrocardiogram were sufficient for 42.7% of HCPs to recommend oral anticoagulation for patients at high risk for stroke. Respondents wanted more data comparing the accuracy of digital devices to conventional devices for AF monitoring (64.9%). A quarter (27.3%) of HCPs had no reservations recommending digital devices for AF detection, and most (53.4%) wanted guidelines from their professional societies providing guidance on their optimal use. CONCLUSION Many HCPs have already integrated digital devices into their clinical practice. However, HCPs reported facing challenges when using digital technologies for AF detection,

show abstract

TeleCheck-AF for COVID-19

Cited by 67 publications

References 0 publications

COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications

COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications

COVID-19 infection and cardiac arrhythmias

Survey of current perspectives on consumer-available digital health devices for detecting atrial fibrillation

Contact Info

Product

Resources

About